• Great chat with @didierleconte and Julie, after the ACCT Dinner & Awards, over some very good scotch. #
  • Twitter, LinkedIn team up for self-promotion free-for-all, http://ow.ly/AXn6 #
  • Angel investor market: more deals but fewer dollars in 2009, study finds, http://ow.ly/ziSP #
  • BP to ramp up biofuel production in coming years, exec says, http://ow.ly/zj2D #
  • Zebrafish may offer clues to organ regeneration, http://ow.ly/zBSg #
  • FDA approves Gloucester's drug for rare skin cancer, http://ow.ly/AWPs #
  • Study: Polymer spheres treat spinal cord injury in rats, http://ow.ly/AWQ0 #
  • Horse genome could offer clues to human diseases, http://ow.ly/AWQo #
  • 5 universities' patent policy aims to boost drug access, http://ow.ly/AWQu #
  • Judge removes 3 restraining orders against ZymoGenetics, http://ow.ly/AWQN #
  • Big, small drugmakers benefit from structured deals, http://ow.ly/AWRc #
  • RT @CBCMontreal: Quebec hit film picked up by Hollywood http://url4.eu/jKMf #
  • RT @didierleconte: Marcel Mongeon notes collaborative research went from $288M to $1,200M in 10 years in Canada (this is knowledge transfer) #
  • The ACCT conference is finished, great experience. Good talks and great people. #
  • Post-conference, going to attend the 2-day ACCT course (Wed-Thurs) on Industry Engagement, here in Victoria (BC). #

Comments are closed.